DURHAM, N.C., Sept. 9, 2010 GLOBE NEWSWIRE — Oxygen Biotherapeutics, Inc. Nasdaq:OXBT SIX Swiss Exchange:OXBT, a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced results for the fiscal year FY first quarter ended July 31, 2010.
Oxygen Biotherapeutics reported a net loss of approximately million, or .13 per share, [...] http://bit.ly/cs0KiZ
No comments:
Post a Comment